Literature DB >> 20841573

Family physicians' choices of and opinions on colorectal cancer screening modalities.

Michael Zettler1, Brent Mollon, Vitor da Silva, Brett Howe, Mark Speechley, Chris Vinden.   

Abstract

OBJECTIVE: To determine FPs' choices of and opinions on colorectal cancer (CRC) screening options in the context of a new provincewide screening program.
METHODS: Mailed survey, using a modified Dillman protocol, which asked about 5 recommended CRC screening modalities.
SETTING: Ontario. PARTICIPANTS: Computer-generated random sample of 894 eligible FPs and GPs from a commercially available physician directory. MAIN OUTCOME MEASURES: Physicians' preferences for personal CRC screening; perceptions of patients' preferences for CRC screening; knowledge of screening test characteristics; and opinions on cost-effectiveness and mortality reduction of screening modalities.
RESULTS: Of the 894 eligible FPs and GPs who received the mailed survey, 465 physicians responded (response rate of 52%). Respondents were diverse in demographic and practice characteristics. Decennial colonoscopy and biennial fecal occult blood testing (FOBT) were the 2 most popular screening methods. There was a statistically significant difference between physicians' preferences of screening options and their perceptions about patient preferences (P<.001), with 50.8% of physicians preferring colonoscopy (vs 39.6% FOBT) but 64.1% believing the average patient prefers FOBT (vs 29.0% colonoscopy). Opinions on the cost-effectiveness and effect on mortality of screening modalities and FOBT sensitivity, but not colonoscopy wait times, significantly influenced both physician preferences and their perceptions of patient preferences. Of the respondents, 54.4% believed colonoscopy had the greatest mortality reduction, while 66.1% chose FOBT as the most cost-effective CRC screening method.
CONCLUSION: There was a significant difference between primary care physicians' preferences and their perceptions of patient preferences for CRC screening (P<.001). Screening choice was influenced by physicians' perceptions of FOBT sensitivity and their opinions on cost-effectiveness and mortality reduction of the screening modality. Colonoscopy wait times did not influence physicians' screening choices. As some screening programs emphasize FOBT for most people, this might result in fewer physican-patient discussions about options of other screening modalities. Further research into patient preferences for screening is warranted.

Entities:  

Mesh:

Year:  2010        PMID: 20841573      PMCID: PMC2939135     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

Review 1.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

Authors:  S Vijan; E W Hwang; T P Hofer; R A Hayward
Journal:  Am J Med       Date:  2001-12-01       Impact factor: 4.965

3.  Patient preferences for colorectal cancer screening.

Authors:  L E Leard; T J Savides; T G Ganiats
Journal:  J Fam Pract       Date:  1997-09       Impact factor: 0.493

4.  Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Authors:  A Sonnenberg; F Delcò; J M Inadomi
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

5.  Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy.

Authors:  Joseph J Y Sung; Francis K L Chan; Wai K Leung; Justin C Y Wu; James Y W Lau; Jessica Ching; Ka F To; Yuk T Lee; Yiu W Luk; Nelson N S Kung; Samuel P Y Kwok; Michael K W Li; S C Sydney Chung
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

6.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors:  B Towler; L Irwig; P Glasziou; J Kewenter; D Weller; C Silagy
Journal:  BMJ       Date:  1998-08-29

7.  Colorectal cancer screening: practices and opinions of primary care physicians.

Authors:  S Elizabeth McGregor; Robert J Hilsden; Alison Murray; Heather E Bryant
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

8.  Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.

Authors:  Paul Ritvo; Ronald Myers; M Elisabeth Del Giudice; Lawrence Pazsat; Michelle Cotterchio; Roberta Howlett; Verna Mai; Patrick Brown; Terrence Sullivan; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

Review 9.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

10.  Adherence to colorectal cancer screening guidelines in Canada.

Authors:  Maida J Sewitch; Caroline Fournier; Antonio Ciampi; Alina Dyachenko
Journal:  BMC Gastroenterol       Date:  2007-10-02       Impact factor: 3.067

View more
  7 in total

1.  Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems.

Authors:  Nirupa R Ghai; Christopher D Jensen; Sophie A Merchant; Joanne E Schottinger; Jeffrey K Lee; Jessica Chubak; Aruna Kamineni; Ethan A Halm; Celette Sugg Skinner; Jennifer S Haas; Beverly B Green; Nancy T Cannizzaro; Jennifer L Schneider; Douglas A Corley
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-15

2.  Colorectal cancer screening practices in Saskatchewan: Survey of family physicians.

Authors:  Ray Deobald; Peter Graham; Jennifer Chad; Carlo Di Gregorio; Jennifer Johnstone; Lloyd Balbuena; Chris Kenyon; Mark Lees
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

3.  Equity and practice issues in colorectal cancer screening: Mixed-methods study.

Authors:  Sandy Buchman; Linda Rozmovits; Richard H Glazier
Journal:  Can Fam Physician       Date:  2016-04       Impact factor: 3.275

4.  Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians.

Authors:  Christopher Wallis; Douglas Cheung; Laurence Klotz; Venu Chalasani; Ricardo Leao; Juan Garisto; Gerard Morton; Robert Nam; Ian Tannock; Raj Satkunasivam
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

5.  Patient Test Preference for Colorectal Cancer Screening and Screening Uptake in an Insured Urban Minority Population.

Authors:  Randi L Wolf; Charles E Basch; Patricia Zybert; Corey H Basch; Ralph Ullman; Celia Shmukler; Fionnuala King; Alfred I Neugut
Journal:  J Community Health       Date:  2016-06

6.  Perceived barriers and facilitators of using a Web-based interactive decision aid for colorectal cancer screening in community practice settings: findings from focus groups with primary care clinicians and medical office staff.

Authors:  Masahito Jimbo; Cameron Garth Shultz; Donald Eugene Nease; Michael Derwin Fetters; Debra Power; Mack Thomas Ruffin
Journal:  J Med Internet Res       Date:  2013-12-18       Impact factor: 5.428

7.  Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA.

Authors:  Benjamin E Ansa; Nicollette Lewis; Zachary Hoffman; Biplab Datta; J Aaron Johnson
Journal:  Healthcare (Basel)       Date:  2021-05-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.